Chemodex

β-Nicotinamide adenine dinucleotide phosphate

CHF 150.00
In stock
CDX-N0151-M500500 mgCHF 150.00
CDX-N0151-G0011 gCHF 237.00
More Information
Product Details
Synonyms Coenzyme II; β-NADP; NADP+; TPN; Triphosphopyridine nucleotide sodium salt hydrate
Product Type Chemical
Properties
Formula

C21H27N7NaO17P3 . xH2O

MW 765.39 (anhydrous basis)
CAS 698999-85-8
Source/Host Chemicals Synthetic
Purity Chemicals ≥98% (HPLC)
Appearance White to off-white powder.
Solubility Soluble in water (30mg/ml).
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key JNUMDLCHLVUHFS-QYZPTAICSA-M
Smiles O[C@H]1[C@@H](OP(O)(O)=O)[C@H](N2C=NC3=C2N=CN=C3N)O[C@@H]1COP([O-])(OP(OC[C@@H]4[C@@H](O)[C@@H](O)[C@H]([N+]5=CC(C(N)=O)=CC=C5)O4)([O-])=O)=O.[Na+]
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

NADP+ is the oxidized form of the electron donor nicotinamide adenine dinucleotide phosphate. It is a cofactor used in anabolic reactions, such as the Calvin cycle, lipid syntheses and nucleic acid syntheses, which require NADPH as a reducing agent. It serves as a cofactor in various biological reactions. In addition, the balance between these reduced and oxidized forms plays key roles in diverse cellular functions, including cell survival, the maintenance of redox status and intracellular signaling. For example, binding of NADP+ to β-subunits of Kv channels activates ion transport, whereas NADPH stabilizes channel inactivation. NADP+ is biosynthesized from NAD+ by NAD kinase, with ATP as the phosphoryl donor. NADP+ might be useful for immunometabolism research.

Product References

(1) F. Shi, et al.; Acta Biochim. Biophys. Sin. 41, 352 (2009) | (2) J.B. Jackson; BBA 1817, 1839 (2012) | (3) M. Nakamura, et al.; Circ. Res. 111, 604 (2012) | (4) P.J. Kilfoil, et al.; Circ. Res. 112, 721 (2013) | (5) M. Ziegler; FEBS J. 272, 4561 (2014) | (6) R. Ramalho, et al.; Sem. Immunopathol. 42, 279 (2020)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.